2022
DOI: 10.1016/j.expneurol.2022.114054
|View full text |Cite
|
Sign up to set email alerts
|

Spinal motor neuron transplantation to enhance nerve reconstruction strategies: Towards a cell therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 63 publications
0
5
0
Order By: Relevance
“…A recent review article focused on neuromuscular preservation for denervated muscles using spinal motor neuron (SMN) transplantation and discussed permanent treatment strategies with electrical stimulation [ 27 ]. In the article, the authors discuss not only reconstruction of motor function due to complete conus and cauda equina injury, but also reconstruction of bladder function and application of diaphragmatic pacing for ALS.…”
Section: Discussionmentioning
confidence: 99%
“…A recent review article focused on neuromuscular preservation for denervated muscles using spinal motor neuron (SMN) transplantation and discussed permanent treatment strategies with electrical stimulation [ 27 ]. In the article, the authors discuss not only reconstruction of motor function due to complete conus and cauda equina injury, but also reconstruction of bladder function and application of diaphragmatic pacing for ALS.…”
Section: Discussionmentioning
confidence: 99%
“…Replenishing injured or lost spinal cord motor neurons is an effective strategy for promoting neural reconstruction and may contribute to improving injured spinal cord function ( Bazarek et al, 2022 ). The forced expression of seven TFs (Ascl1, Brn2, Myt1l, Lhx3, Hb9, Isl1, and NeuroG2) transdifferentiates mouse fibroblasts into induced motor neurons (iMNs).…”
Section: Transdifferentiation Of Neuronal Subtypesmentioning
confidence: 99%
“…The pipeline of therapies designed to promote peripheral reinnervation or slow degeneration in a multitude of conditions is expanding dramatically. This is typified by the explosion in amyotrophic lateral sclerosis (ALS) trials to slow or reverse degeneration, immune therapies in inflammatory conditions, and the numerous therapeutic avenues in peripheral nerve injury including stimulation, stem cells, growth factors, and varied surgical techniques [3][4][5][6][7]. This context demands a re-evaluation of standard clinical and pre-clinical measurements of nerve health and the innovation of measures that can serve as novel biomarkers.…”
Section: Introductionmentioning
confidence: 99%